Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at ULTA's multiple
$1.8354.1% below market
0.94 ZNTL revenue / share×1.95x ULTA P/S=$1.83
Market $3.99Implied $1.83
ULTA · current priceP/S 1.95x
$564.12Latest market snapshot
Implied fair value · at ZNTL's multiple
$1,229.30117.9% above market
289.84 ULTA revenue / share×4.24x ZNTL P/S=$1,229.30
Market $564.12Implied $1,229.30